From July 1, 2022 to July 24, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 23,457,523 shares, representing 2.12% for CNY 602.01 million under the buyback announced on July 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.17 CNY | -1.02% | -2.35% | -4.56% |
04-23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
04-23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.56% | 4.76B | |
+20.83% | 43.57B | |
+20.70% | 22.7B | |
+16.41% | 14.32B | |
+11.11% | 13.42B | |
+45.91% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.51B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on July 26, 2021.